〇Koji Kubouchi1, Sally Danno1, Akira Nomachi2, Takako Hirata3, Kazuhiko Matsuo4, Takashi Nakayama4, Ryosuke Satoh5, Reiko Sugiura5, Manabu Abe6, Kenji Sakimura6, Shigeharu Wakana7, Hiroyuki Ohsaki8, Shingo Kamoshida8, Hideyuki Mukai1,9
(1.Graduate School of Medicine, Kobe University, 2.Center for Innovation in Immunoregulative Technology and Therapeutics, Kyoto University Graduate School of Medicine, 3.Department of Fundamental Biosciences, Shiga University of Medical Science, 4.Division of Chemotherapy, Kindai University School of Pharmacy, 5.Laboratory of Molecular Pharmacogenomics, School of Pharmaceutical Sciences, Kindai University, 6.Department of Cellular Neurobiology, Brain Research Institute, Niigata University, 7.Japan Mouse Clinic, RIKEN BioResource Center,, 8.Laboratory of Pathology, Department of Medical Biophysics, Kobe University Graduate School of Health Sciences, 9.Biosignal Research Center)
ConBio2017